135716-08-4

Basic information

• Product Name: tert-butyl 4-(2-ethoxy-2-oxoethylidene)piperidine-1-carboxylate
• Synonyms: tert-butyl 4-(2-ethoxy-2-oxoethylidene)piperidine-1-carboxylate;1-piperidinecarboxylic acid, 4-(2-ethoxy-2-oxoethylidene)-;tert-Butyl 4-(2-ethoxy-2-oxoethylidene)tetrahydro-1(2H)-pyridinecarboxylate;[1-(tert-Butoxycarbonyl)piperidin-4-ylidene]acetic acid ethyl ester;4-(2-Ethoxy-2-oxoethylidene)-1-piperidinecarboxylic acid tert-butyl ester;4-(Ethoxycarbonylmethylene)-1-(tert-butoxycarbonyl)piperidine;4-[(Ethoxycarbonyl)methylene]piperidine-1-carboxylic acid tert-butyl ester;tert-Butyl 4-(2-ethoxy-2-oxoethylidene)-1-piperidinecarboxylate
• CAS NO: 135716-08-4
• Molecular Formula: C₁₄H₂₃NO₄
• Molecular Weight: 269.339
• Mol File: 135716-08-4.mol
• Article Data: 60

Chemical Properties

• Melting Point: 85 °C
• Boiling Point: 354℃
• Flash Point: 168℃
• Appearance: /
• Density: 1.129
• Storage Temp.: 2-8°C
• PKA: -1.46±0.20(Predicted)
• CAS DataBase Reference: tert-butyl 4-(2-ethoxy-2-oxoethylidene)piperidine-1-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl 4-(2-ethoxy-2-oxoethylidene)piperidine-1-carboxylate(135716-08-4)
• EPA Substance Registry System: tert-butyl 4-(2-ethoxy-2-oxoethylidene)piperidine-1-carboxylate(135716-08-4)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 135716-08-4(Hazardous Substances Data)

Usage

General Description

Tert-butyl 4-(2-ethoxy-2-oxoethylidene)piperidine-1-carboxylate is a chemical compound with a complex structure consisting of a tert-butyl group attached to a piperidine ring. The piperidine ring is further functionalized with a carboxylate group and an ethoxyketene acetal group. This chemical compound has potential applications in the field of organic synthesis and drug discovery due to its unique structure and reactivity. It may be used as a building block in the synthesis of various pharmaceuticals and organic compounds, where its ethoxyketene acetal moiety can serve as a versatile protecting group for aldehydes and ketones, allowing for selective chemical transformations. Further research and experimentation are required to uncover the precise properties and applications of this compound.

InChI:InChI=1S/C14H23NO4/c1-5-18-12(16)10-11-6-8-15(9-7-11)13(17)19-14(2,3)4/h10H,5-9H2,1-4H3

Upstream product

• 867-13-0 diethoxyphosphoryl-acetic acid ethyl ester 
• 79099-07-3 N-tert-butyloxycarbonylpiperidin-4-one 
• 311-46-6 ethyl 2-(dimethoxyphosphoryl)acetate 
• 41661-47-6 piperidin-4-one 
• 50893-53-3 carbonochloridic acid 1-chloro-ethyl ester 
• 24424-99-5 di-tert-butyl dicarbonate 
• 40110-55-2 ethyl 2-(1-benzylpiperidine-4-ylidene)acetate 
• 1099-45-2 ethyl (triphenylphosphoranylidene)acetate 
• 10419-80-4 O,O-diethyl ethoxymethylphosphonate 
• 41979-39-9 4-piperidone hydrochloride 

Downstream Products

• 198892-80-7 t-butyl 4-(2-hydroxyethylidene)tetrahydropyridine-1(2H)-carboxylate 
• 135716-09-5 tert-butyl 4-(2-ethoxy-2-oxoethyl)piperidine-1-carboxylate 
• 1259040-07-7 8-(tert-butyl) 4-ethyl 2-benzyl-2,8-diazaspiro[4.5]decane-4,8-dicarboxylate 
• 1259040-06-6 2-(4-{[bis(1H-imidazol-2-ylmethyl)amino]methyl}benzyl)-8-(1-ethylpropyl)-2,8-diazaspiro[4.5]decane-4-carboxylic acid 
• 1259040-08-8 C₁₈H₂₆N₂O₂ 
• 1259040-09-9 C₂₃H₃₆N₂O₂ 
• 1259040-11-3 C₃₂H₄₇N₇O₂ 
• 301221-63-6 tert-butyl 4-(1-bromo-2-oxoethyl)piperidine-1-carboxylate 
• 301221-19-2 tert-butyl 4-(imidazo[1,2-a]pyridin-3-yl)piperidine-1-carboxylate 
• 1032825-55-0 tert-butyl 4-(1-((methylsulfonyl)oxy)ethyl)piperidine-1-carboxylate 
• 161315-55-5 3-[2-(N-t-BOC-4-piperidinyl)-1-oxoethyl]-4(R)-(benzyl)-2-oxazolidinone 
• 157688-46-5 2-(1-(tert-butoxycarbonyl)piperidin-4-yl)acetic acid 
• 1292322-22-5 C₂₀H₂₉F₂N₃O 
• 1292322-20-3 C₂₀H₂₈F₂N₂O₂ 

Relevant articles and documents

Substituted furo[3,2-b]pyridines: Novel bioisosteres of 5-HT1F receptor agonists

Synthesis and evaluation of a series of 2,3,5- and 3,5-substituted furo[3,2-b]pyridines were undertaken in order to investigate their utility as bioisosteres of 5-HT1F receptor agonist indole analogues, 1-3. The replacement proved to be effective, providing compounds with similar 5-HT 1F receptor affinity and improved selectivity when compared with the indole analogues. Through these studies we identified 4-fluoro-N-[3-(1-methyl- piperidin-4-yl)-furo[3,2-b]pyridin-5-yl]-benzamide (5), a potent and selective 5-HT1F receptor agonist with the potential to treat acute migraine.

Design, Synthesis, and Biological Evaluation of Novel Pyrimido[4,5-b]indole Derivatives against Gram-Negative Multidrug-Resistant Pathogens

Due to the poor permeability across Gram-negative bacterial membranes and the troublesome bacterial efflux mechanism, only a few GyrB/ParE inhibitors with potent activity against Gram-negative pathogens have been reported. Among them, pyrimido[4,5-b]indol

COMBINATIONS COMPRISING BENZODIOXOL AS GLP-1R AGONISTS FOR USE IN THE TREATMENT OF NASH/NAFLD AND RELATED DISEASES

In part, the invention provides a new combination comprising (1) a GLP-1R agonist and (2) an ACC inhibitor or a DGAT2 inhibitor, or a KHK inhibitor or FXR agonist. The invention further provides new methods for treating diseases and disorders, for example, fatty liver, nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, nonalcoholic steatohepatitis with liver fibrosis, nonalcoholic steatohepotitis with cirrhosis, and nonalcoholic steatohepatitis with cirrhosis and with hepatocellular carcinoma or with a metabolic-related disease, obesity, and type 2 diabetes, for example, using the new combination described herein.